2021
DOI: 10.1053/j.gastro.2020.06.054
|View full text |Cite
|
Sign up to set email alerts
|

An Enlarging Hepatic Mass of Unknown Etiology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 2 publications
0
3
0
Order By: Relevance
“…( 17 ) in 1976, is now also classified as PEComa. Recent papers reported a prevalence of hepatic PEComa to be 300-600 cases, but it is problematic to estimate true epidemiology ( 18 , 19 ). There is a higher prevalence of various neoplasms in organ transplant recipients ( 6 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…( 17 ) in 1976, is now also classified as PEComa. Recent papers reported a prevalence of hepatic PEComa to be 300-600 cases, but it is problematic to estimate true epidemiology ( 18 , 19 ). There is a higher prevalence of various neoplasms in organ transplant recipients ( 6 ).…”
Section: Discussionmentioning
confidence: 99%
“…In liver PEComa, those criteria were not validated. Case reports of hepatic lesions with malignant behavior were reported and most of them did not meet the criteria ( 18 , 28 , 41 44 ).…”
Section: Discussionmentioning
confidence: 99%
“…1,2 Their most frequent location is the uterus, followed by the kidneys, bladder, prostate, lung, pancreas, and liver. 2 Primary hepatic PEComa is extremely rare, with most cases being benign, and only a few cases being malignant. Based on some case reports published, the abnormal FDG distribution in PEComa varies widely.…”
Section: Figurementioning
confidence: 99%
“…In a follow-up period of 6 months after transcatheter arterial chemoembolization, the tumor had shrunk without metastasis by MRI. PEComas are a rare group of mesenchymal tumors, distinguished by epithelioid cells with perivascular disposition, which express myogenic and melanocytic markers 1,2. Their most frequent location is the uterus, followed by the kidneys, bladder, prostate, lung, pancreas, and liver 2.…”
mentioning
confidence: 99%
See 1 more Smart Citation